International Journal of Cancer Management

Published by: Kowsar

Simultaneous Presentation of Cerebellopontine Angle Pleomorphic Xanthoastrocytoma and Malignant Melanoma in a Known Case of Neurofibromatosis 1; Probable Role of BRAF Gene: A Case Report and Review of Literature

Amir Saied Seddighi 1 , Afsoun Seddighi 1 , * , Sima Behrouzian 1 and Amir Nikouei 1
Authors Information
1 Shohada Tajrish Neurosurgical Center of Excellence, Functional Neurosurgery Research Center of Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: July 2017, 10 (7); e7211
  • Published Online: July 31, 2017
  • Article Type: Case Report
  • Received: May 21, 2016
  • Revised: July 3, 2016
  • Accepted: July 2, 2017
  • DOI: 10.5812/ijcm.7211

To Cite: Seddighi A S, Seddighi A, Behrouzian S, Nikouei A. Simultaneous Presentation of Cerebellopontine Angle Pleomorphic Xanthoastrocytoma and Malignant Melanoma in a Known Case of Neurofibromatosis 1; Probable Role of BRAF Gene: A Case Report and Review of Literature, Int J Cancer Manag. 2017 ; 10(7):e7211. doi: 10.5812/ijcm.7211.

Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Giannini C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, et al. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer. 1999; 85(9): 2033-45[PubMed]
  • 2. Riccardi VM, Smirniotopoulos J. Neurofibromatosis, Phenotype, Natural History, and Pathogenesis. J Neuropathol Exp Neurol. 1992; 51(6): 658[DOI]
  • 3. Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994; 125(1): 63-6[PubMed]
  • 4. Neal MT, Ellis TL, Stanton CA. Pleomorphic xanthoastrocytoma in two siblings with neurofibromatosis type 1 (NF-1). Clin Neuropathol. 2012; 31(1): 54-6[PubMed]
  • 5. Houghton AN, Polsky D. Focus on melanoma. Cancer Cell. 2002; 2(4): 275-8[PubMed]
  • 6. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002; 417(6892): 949-54[DOI][PubMed]
  • 7. Dias-Santagata D, Lam Q, Vernovsky K, Vena N, Lennerz JK, Borger DR, et al. BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications. PLoS One. 2011; 6(3)[DOI][PubMed]
  • 8. Hirbe AC, Pekmezci M, Dahiya S, Apicelli AJ, Van Tine BA, Perry A, et al. BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Neuro Oncol. 2014; 16(3): 466-7[DOI][PubMed]
  • 9. Adeleye AO, Okolo CA, Akang EE, Adesina AM. Cerebral pleomorphic xanthoastrocytoma associated with NF1: an updated review with a rare atypical case from Africa. Neurosurg Rev. 2012; 35(3): 313-9[DOI][PubMed]
  • 10. Hirose T, Ishizawa K, Sugiyama K, Kageji T, Ueki K, Kannuki S. Pleomorphic xanthoastrocytoma: a comparative pathological study between conventional and anaplastic types. Histopathology. 2008; 52(2): 183-93[DOI][PubMed]
  • 11. Naidich MJ, Walker MT, Gottardi-Littell NR, Han G, Chandler JP. Cerebellar pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1. Neuroradiology. 2004; 46(10): 825-9[DOI][PubMed]
  • 12. Kurschel S, Lellouch-Tubiana A, Kulkarni AV, Sainte-Rose C. Pleomorphic xanthoastrocytoma of the cerebellopontine angle in a child. Childs Nerv Syst. 2006; 22(11): 1479-82[DOI][PubMed]
  • 13. Crespo-Rodriguez AM, Smirniotopoulos JG, Rushing EJ. MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature. Neuroradiology. 2007; 49(4): 307-15[DOI][PubMed]
  • 14. Dougherty MJ, Santi M, Brose MS, Ma C, Resnick AC, Sievert AJ, et al. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol. 2010; 12(7): 621-30[DOI][PubMed]
  • 15. Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol. 2011; 121(3): 397-405[DOI][PubMed]
  • 16. Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, et al. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma. Am J Surg Pathol. 2013; 37(1): 61-5[DOI][PubMed]
  • 17. Serrano C, Simonetti S, Hernandez-Losa J, Valverde C, Carrato C, Bague S, et al. BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumours. Histopathology. 2013; 62(3): 499-504[DOI][PubMed]
  • 18. MacConaill LE, Campbell CD, Kehoe SM, Bass AJ, Hatton C, Niu L, et al. Profiling critical cancer gene mutations in clinical tumor samples. PLoS One. 2009; 4(11)[DOI][PubMed]
  • 19. Flaherty KT. Narrative review: BRAF opens the door for therapeutic advances in melanoma. Ann Intern Med. 2010; 153(9): 587-91[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments